Search

everythinglearnresearchcommunity

for

Search:↓

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Egyptian researchers are advancing in pharmaceutical nanotechnology, potentially improving health outcomes and the economy.

The new delivery system could improve pain and inflammation relief in gout.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Spanlastics are effective for delivering Meloxicam with improved stability and targeting.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Abatacept may help some people with alopecia areata regrow hair.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Mesalazine may help treat extensive alopecia areata effectively.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Fissistigma oldhamii has compounds that help with pain, inflammation, and other health issues.

Tofacitinib helped a woman with total-body hair loss grow her hair back.